Stoplisp
arrow_back

Ventures

Stoplisp

Digital Therapeutics for people who speak with a lisp.

Current situation

To have a lisp is one of the most common speech defects worldwide – regardless of language. In Germany, over 5 million people are affected: 3.8 million adults and 1.5 million children.

What we offer

Stoplisp is the first global digital therapeutic for people who speak with a lisp based on artificial intelligence.

Why this is important

Only 5% adults receive speech therapy , even though an untreated lisp persists for lifetime. However, with the right method and regular training lisping can be treated effectively within 6 month.